Table 2.

Clinicopathological characteristics of Solicoccozyma at the genus level in GC patients.

Characteristics	Solicoccozyma expression		P value
	Positive (n = 27)	Negative (n = 34)
Age
≥60	13 (48.1%)	14 (41.2%)
<60	14 (51.9%)	20 (58.8%)	0.586
Gender
Male	17 (63.0%)	26 (76.5%)
Female	10 (37.0%)	8 (23.5%)	0.251
Body mass index
<18	1 (3.70%)	2 (5.9%)
18-24	19 (70.4%)	22 (64.7%)
>24	7 (25.9%)	10 (29.4%)	0.868
Tumor location
Upper	9 (33.3%)	10 (29.4%)
Middle/lower	18 (66.7%)	24 (70.6%)	0.743
Tumor differentiation
High	3 (11.1%)	1 (2.9%)
Moderately/poor	24 (88.9%)	33 (97.1%)	0.200
Lauren classification
Diffuse	13 (48.2%)	23 (67.6%)
Intestinal	10 (37.0%)	7 (20.6%)
Mix	4 (14.8%)	4 (11.8%)	0.281
Bormann classification
I-II	6 (22.2%)	1 (2.9%)
III-IV	21 (77.8%)	33 (97.1%)	0.019 ∗
Tumor size (max)
>4 cm	16 (59.3%)	24 (70.6%)
<4 cm	11 (40.7%)	10 (29.4%)	0.355
Pathological stage
I-II	8 (29.6%)	7 (20.6%)
III-IV	19 (70.4%)	27 (79.4%)	0.415
Tumor depth
T1-T2	4 (14.8%)	5 (14.7%)
T3-T4	23 (85.2%)	29 (85.3%)	0.990
Lymph node metastasis
N0	10 (37.0%)	7 (20.6%)
N1/N2/N3	17 (63.0%)	27 (79.4%)	0.155
Distant metastasis
M0	21 (77.8%)	28 (82.4%)
M1	6 (22.2%)	6 (17.6%)	0.655
Lymphatic vessel invasive (D2-40)
Yes	6 (22.2%)	14 (41.2%)
No	21 (77.8%)	20 (58.8%)	0.117
Vascular invasive (CD31)
Yes	5 (18.5%)	10 (29.4%)
No	22 (81.5%)	24 (70.6%)	0.326
Nerve invasive (S-100)
Yes	17 (63.0%)	29 (85.3%)
No	10 (37.0%)	5 (14.7%)	0.044∗
HER2 status
0/1+/2+	22 (81.5%)	31 (91.2%)
3+	5 (18.5%)	3 (8.8%)	0.265
PD-L1 status
CPS ≥ 10	9 (33.3%)	15 (44.1%)
CPS < 10	18 (66.7%)	19 (55.9%)	0.392

^∗ P < 0.05 was considered significant.